Stay updated with breaking news from Vor Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
04.06.2024 - CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) - Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the Compensation Committee of the Board of Directors granted stock ...
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
21.12.2023 - CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) - Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of December 20, 2023, the Compensation Committee of the Board of Directors granted ...
CAMBRIDGE, Mass., Dec. 21, 2023 -- Vor Bio , a clinical-stage cell and genome engineering company, today announced that, effective as of December 20, 2023, the Compensation Committee of the Board...
Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to date • All three patients receiving multiple Mylotarg™ doses exhibited…